LeafWorks Inc.

LeafWorks Inc. is a botanical genomics company focused on advanced DNA testing and consulting services, specifically for the natural products industry, including cannabis, hemp, and functional mushrooms. Founded in 2016 in Sebastopol, US, LeafWorks Inc. specializes in botanical genomics.

The company has not undergone significant pivots in its strategy and does not have known subsidiaries. The founders, Eleanor Kuntz and Kerin Law, bring extensive expertise to the company. In February 2020, LeafWorks raised USD 1 million in Series A funding led by Bonaventure Capital, bringing the total amount raised to USD 1 million. LeafWorks provides DNA testing and consulting services tailored for the natural products industry, particularly focused on cannabis, hemp, and functional mushrooms.

Their offerings include DNA sex tests for cannabis and hemp, pathogen identification, and certification services, which aim to enhance product quality and authenticity. The company also features a Mushroom Ingredient DNA Validation Program to ensure transparency and regulatory compliance. Revenue is generated through direct service sales and consulting partnerships. LeafWorks’ main services include the Cannabis & Hemp DNA Sex Test and Mushroom DNA Testing, priced based on the complexity of the tests.

Clients can also receive tailored consulting services, leading to ongoing relationships and repeat business, structured on a fee-for-service basis. Following the successful Series A funding in February 2020, LeafWorks plans to invest in the development of new products and launch initiatives targeting broader markets. Specific markets for expansion include North America and Europe, with a focus on enhancing their service offerings in these regions. The recent funding will support these growth strategies and initiatives aimed at improving product quality and compliance.